Detalhe da pesquisa
1.
FAT10 induces immune suppression by upregulating PD-L1 expression in hepatocellular carcinoma.
Apoptosis
; 2024 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38824477
2.
Identification of FOXP1 as a favorable prognostic biomarker and tumor suppressor in intrahepatic cholangiocarcinoma.
BMC Cancer
; 24(1): 137, 2024 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38279090
3.
Genetic and clinical landscape of ER + /PR- breast cancer in China.
BMC Cancer
; 23(1): 1189, 2023 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38049758
4.
Identification of LIPH as an unfavorable biomarkers correlated with immune suppression or evasion in pancreatic cancer based on RNA-seq.
Cancer Immunol Immunother
; 71(3): 601-612, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34279685
5.
Prognostic values and immune suppression of the S100A family in pancreatic cancer.
J Cell Mol Med
; 25(6): 3006-3018, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33580614
6.
Characterization of the prognostic and oncologic values of ITGB superfamily members in pancreatic cancer.
J Cell Mol Med
; 24(22): 13481-13493, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33073486
7.
A four prognosis-associated lncRNAs (PALnc) based risk score system reflects immune cell infiltration and predicts patient survival in pancreatic cancer.
Cancer Cell Int
; 20: 493, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33061845
8.
Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma.
Cancer Cell Int
; 20: 27, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32002016
9.
Identification of N7-methylguanosine-related miRNAs as potential biomarkers for prognosis and drug response in breast cancer.
Heliyon
; 10(8): e29326, 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38628712
10.
FLNB overexpression promotes tumor progression and associates with immune suppression, evasion and stemness in pancreatic cancer.
Am J Cancer Res
; 14(2): 709-726, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38455418
11.
CircNUP54 promotes hepatocellular carcinoma progression via facilitating HuR cytoplasmic export and stabilizing BIRC3 mRNA.
Cell Death Dis
; 15(3): 191, 2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38443362
12.
A novel risk score system based on immune subtypes for identifying optimal mRNA vaccination population in hepatocellular carcinoma.
Cell Oncol (Dordr)
; 2024 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38315287
13.
LINC00909 up-regulates pluripotency factors and promotes cancer stemness and metastasis in pancreatic ductal adenocarcinoma by targeting SMAD4.
Biol Direct
; 19(1): 24, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38504385
14.
Identification of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and Responsiveness to Immunotherapy in Hepatocellular Carcinoma.
J Hepatocell Carcinoma
; 10: 1-16, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36647389
15.
Trends in prevalence and all-cause mortality of metabolic dysfunction-associated fatty liver disease among adults in the past three decades: Results from the NHANES study.
Eur J Intern Med
; 110: 62-70, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36754655
16.
Analysis of Omics Data Reveals Nucleotide Excision Repair-Related Genes Signature in Highly-Grade Serous Ovarian Cancer to Predict Prognosis.
Front Cell Dev Biol
; 10: 874588, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35769257
17.
Identification of MBOAT2 as an Unfavorable Biomarker Correlated with KRAS Activation and Reduced CD8+ T-Cell Infiltration in Pancreatic Cancer.
J Oncol
; 2022: 4269733, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35571489
18.
SLC39A1 Overexpression is Associated with Immune Infiltration in Hepatocellular Carcinoma and Promotes Its Malignant Progression.
J Hepatocell Carcinoma
; 9: 83-98, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35211427
19.
ZMAT1 acts as a tumor suppressor in pancreatic ductal adenocarcinoma by inducing SIRT3/p53 signaling pathway.
J Exp Clin Cancer Res
; 41(1): 130, 2022 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35392973
20.
Downregulation of FXYD2 Is Associated with Poor Prognosis and Increased Regulatory T Cell Infiltration in Clear Cell Renal Cell Carcinoma.
J Immunol Res
; 2022: 4946197, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36313180